Answer
Yes. Its licence covers acute lymphoblastic leukaemia and lymphoblastic lymphoma in the specified asparaginase-replacement setting.
Sources for this answer
- Enrylaze 10 mg/0.5 ml Solution for injection/infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.